Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

被引：0
|
作者：
K A van Nifterik
J van den Berg
W F van der Meide
N Ameziane
L E Wedekind
R D M Steenbergen
S Leenstra
M V M Lafleur
B J Slotman
L J A Stalpers
P Sminia
机构：
[1] VU University Medical Center,Department of Radiation Oncology
[2] VU University Medical Center,Department of Pathology
[3] VU University Medical Center,Department of Clinical Genetics
[4] St Elisabeth Ziekenhuis,Department of Neurosurgery
[5] Academic Medical Center,Department of Radiotherapy
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
MGMT; temozolomide; glioma; prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：29 / 35
页数：6
相关论文
共 50 条
  • [1] Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
    van Nifterik, K. A.
    van den Berg, J.
    van der Meide, W. F.
    Ameziane, N.
    Wedekind, L. E.
    Steenbergen, R. D. M.
    Leenstra, S.
    Lafleur, M. V. M.
    Slotman, B. J.
    Stalpers, L. J. A.
    Sminia, P.
    BRITISH JOURNAL OF CANCER, 2010, 103 (01) : 29 - 35
  • [2] MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma
    Donson, Andrew M.
    Addo-Yobo, Steven O.
    Handler, Michael H.
    Gore, Lia
    Foreman, Nicholas K.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (04) : 403 - 407
  • [3] MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma
    Donson, A. M.
    Addo-Yobo, S. O.
    Handler, M. H.
    Gore, L.
    Foreman, N. K.
    NEURO-ONCOLOGY, 2007, 9 (02) : 189 - 189
  • [4] Absence of MGMT promoter methylation in endometrial cancer
    Rimel, B. J.
    Huettner, Phyllis
    PowelL, Matthew A.
    Mutch, David G.
    Goodfellow, Paul J.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 224 - 228
  • [5] Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
    Larraitz Egaña
    Jaione Auzmendi-Iriarte
    Joaquin Andermatten
    Jorge Villanua
    Irune Ruiz
    Alejandro Elua-Pinin
    Paula Aldaz
    Arrate Querejeta
    Cristina Sarasqueta
    Felix Zubia
    Ander Matheu
    Nicolas Samprón
    Scientific Reports, 10
  • [6] Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
    Egana, Larraitz
    Auzmendi-Iriarte, Jaione
    Andermatten, Joaquin
    Villanua, Jorge
    Ruiz, Irune
    Elua-Pinin, Alejandro
    Aldaz, Paula
    Querejeta, Arrate
    Sarasqueta, Cristina
    Zubia, Felix
    Matheu, Ander
    Sampron, Nicolas
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [7] THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND THE MGMT PROTEIN IN GLIOBLASTOMAS
    Jung, Tae-Young
    Cao, Van Thang
    Jung, Shin
    Jin, Shu-Guang
    Moon, Kyung-Sub
    Kim, In-Young
    Kang, Sam-Suk
    Park, Chang-Soo
    Lee, Kyung-Hwa
    NEURO-ONCOLOGY, 2009, 11 (06) : 944 - 944
  • [8] Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
    Zappe, Katja
    Puehringer, Katharina
    Pflug, Simon
    Berger, Daniel
    Boehm, Andreas
    Spiegl-Kreinecker, Sabine
    Cichna-Markl, Margit
    CELLS, 2023, 12 (12)
  • [9] THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS
    Cao, Van Thang
    Lung, Tae-Young
    Jung, Shin
    Jin, Shu-Guang
    Moon, Kyung-Sub
    Kim, In-Young
    Kang, Sam-Suk
    Park, Chang-Soo
    Lee, Kyung-Hwa
    Chae, Hong-Jae
    NEUROSURGERY, 2009, 65 (05) : 866 - 875
  • [10] A CONTINUUM OF MGMT PROMOTER METHYLATION AND MGMT ACTIVITY
    Alshami, Jad
    Sabau, Carmen
    Sadr, Mohamad Seyed
    Anan, Mitsuhiro
    Sadr, Emad Seyed
    Sin, Vince
    Del Maestro, Rolando
    NEURO-ONCOLOGY, 2010, 12 : 17 - 17
12345